nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Progesterone—uterine cancer	0.123	0.249	CbGbCtD
Perhexiline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.118	0.239	CbGbCtD
Perhexiline—CYP3A4—Progesterone—uterine cancer	0.0783	0.159	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—uterine cancer	0.0778	0.158	CbGbCtD
Perhexiline—Walking disability—Progesterone—uterine cancer	0.0454	0.141	CcSEcCtD
Perhexiline—CYP2D6—Doxorubicin—uterine cancer	0.0376	0.0761	CbGbCtD
Perhexiline—CYP3A4—Etoposide—uterine cancer	0.035	0.0709	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—uterine cancer	0.0239	0.0484	CbGbCtD
Perhexiline—Cachexia—Medroxyprogesterone Acetate—uterine cancer	0.0166	0.0516	CcSEcCtD
Perhexiline—Papilloedema—Medroxyprogesterone Acetate—uterine cancer	0.0149	0.0464	CcSEcCtD
Perhexiline—CPT2—myometrium—uterine cancer	0.0136	0.0892	CbGeAlD
Perhexiline—CPT2—uterine cervix—uterine cancer	0.0106	0.0694	CbGeAlD
Perhexiline—CPT1A—renal system—uterine cancer	0.0104	0.0684	CbGeAlD
Perhexiline—CPT2—decidua—uterine cancer	0.0101	0.0661	CbGeAlD
Perhexiline—CPT2—renal system—uterine cancer	0.00988	0.0649	CbGeAlD
Perhexiline—CPT2—endometrium—uterine cancer	0.00955	0.0628	CbGeAlD
Perhexiline—CPT2—mammalian vulva—uterine cancer	0.00924	0.0607	CbGeAlD
Perhexiline—CPT2—uterus—uterine cancer	0.0088	0.0579	CbGeAlD
Perhexiline—Balance disorder—Medroxyprogesterone Acetate—uterine cancer	0.00868	0.027	CcSEcCtD
Perhexiline—Optic neuritis—Progesterone—uterine cancer	0.00851	0.0264	CcSEcCtD
Perhexiline—CPT1A—female reproductive system—uterine cancer	0.00833	0.0548	CbGeAlD
Perhexiline—CPT2—female reproductive system—uterine cancer	0.00791	0.052	CbGeAlD
Perhexiline—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00771	0.024	CcSEcCtD
Perhexiline—CPT1A—female gonad—uterine cancer	0.00758	0.0499	CbGeAlD
Perhexiline—CPT1A—vagina—uterine cancer	0.00754	0.0496	CbGeAlD
Perhexiline—CPT2—female gonad—uterine cancer	0.0072	0.0473	CbGeAlD
Perhexiline—CPT2—vagina—uterine cancer	0.00715	0.047	CbGeAlD
Perhexiline—Gait disturbance—Progesterone—uterine cancer	0.00536	0.0167	CcSEcCtD
Perhexiline—Cachexia—Epirubicin—uterine cancer	0.00525	0.0163	CcSEcCtD
Perhexiline—Hepatocellular injury—Progesterone—uterine cancer	0.00524	0.0163	CcSEcCtD
Perhexiline—CPT1A—lymph node—uterine cancer	0.00488	0.0321	CbGeAlD
Perhexiline—Cachexia—Doxorubicin—uterine cancer	0.00486	0.0151	CcSEcCtD
Perhexiline—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.0147	CcSEcCtD
Perhexiline—CPT2—lymph node—uterine cancer	0.00463	0.0304	CbGeAlD
Perhexiline—Polyneuropathy—Epirubicin—uterine cancer	0.00461	0.0143	CcSEcCtD
Perhexiline—Optic neuritis—Etoposide—uterine cancer	0.00435	0.0135	CcSEcCtD
Perhexiline—Polyneuropathy—Doxorubicin—uterine cancer	0.00426	0.0132	CcSEcCtD
Perhexiline—Diplopia—Progesterone—uterine cancer	0.0038	0.0118	CcSEcCtD
Perhexiline—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00353	0.011	CcSEcCtD
Perhexiline—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.0101	CcSEcCtD
Perhexiline—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00944	CcSEcCtD
Perhexiline—Weight decreased—Progesterone—uterine cancer	0.00297	0.00923	CcSEcCtD
Perhexiline—Neuropathy peripheral—Progesterone—uterine cancer	0.00287	0.00892	CcSEcCtD
Perhexiline—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00837	CcSEcCtD
Perhexiline—Hepatitis—Progesterone—uterine cancer	0.00263	0.00817	CcSEcCtD
Perhexiline—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00808	CcSEcCtD
Perhexiline—CYP2B6—renal system—uterine cancer	0.00257	0.0169	CbGeAlD
Perhexiline—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00791	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—uterine cancer	0.00244	0.00758	CcSEcCtD
Perhexiline—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.0074	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—uterine cancer	0.00226	0.00702	CcSEcCtD
Perhexiline—Tension—Progesterone—uterine cancer	0.00225	0.00698	CcSEcCtD
Perhexiline—Nervousness—Progesterone—uterine cancer	0.00222	0.00691	CcSEcCtD
Perhexiline—Tremor—Progesterone—uterine cancer	0.00214	0.00666	CcSEcCtD
Perhexiline—CYP2B6—female reproductive system—uterine cancer	0.00206	0.0135	CbGeAlD
Perhexiline—Syncope—Progesterone—uterine cancer	0.00205	0.00638	CcSEcCtD
Perhexiline—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00632	CcSEcCtD
Perhexiline—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00626	CcSEcCtD
Perhexiline—Loss of consciousness—Progesterone—uterine cancer	0.00201	0.00625	CcSEcCtD
Perhexiline—Convulsion—Progesterone—uterine cancer	0.00198	0.00616	CcSEcCtD
Perhexiline—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00604	CcSEcCtD
Perhexiline—CYP3A4—renal system—uterine cancer	0.00194	0.0128	CbGeAlD
Perhexiline—CYP2D6—renal system—uterine cancer	0.00191	0.0126	CbGeAlD
Perhexiline—CYP2B6—vagina—uterine cancer	0.00186	0.0122	CbGeAlD
Perhexiline—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00578	CcSEcCtD
Perhexiline—Hepatitis—Dactinomycin—uterine cancer	0.00186	0.00577	CcSEcCtD
Perhexiline—Shock—Progesterone—uterine cancer	0.00184	0.00571	CcSEcCtD
Perhexiline—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00566	CcSEcCtD
Perhexiline—Hyperhidrosis—Progesterone—uterine cancer	0.00181	0.00561	CcSEcCtD
Perhexiline—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00558	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—uterine cancer	0.00178	0.00554	CcSEcCtD
Perhexiline—Anorexia—Progesterone—uterine cancer	0.00178	0.00553	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—uterine cancer	0.00172	0.00536	CcSEcCtD
Perhexiline—Insomnia—Progesterone—uterine cancer	0.00169	0.00525	CcSEcCtD
Perhexiline—Paraesthesia—Progesterone—uterine cancer	0.00168	0.00521	CcSEcCtD
Perhexiline—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00517	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—uterine cancer	0.00165	0.00513	CcSEcCtD
Perhexiline—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00508	CcSEcCtD
Perhexiline—Decreased appetite—Progesterone—uterine cancer	0.00162	0.00505	CcSEcCtD
Perhexiline—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00501	CcSEcCtD
Perhexiline—Fatigue—Progesterone—uterine cancer	0.00161	0.005	CcSEcCtD
Perhexiline—CYP3A4—female reproductive system—uterine cancer	0.00155	0.0102	CbGeAlD
Perhexiline—Gait disturbance—Epirubicin—uterine cancer	0.00154	0.00478	CcSEcCtD
Perhexiline—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00476	CcSEcCtD
Perhexiline—CYP2D6—female reproductive system—uterine cancer	0.00153	0.0101	CbGeAlD
Perhexiline—Gastrointestinal pain—Progesterone—uterine cancer	0.00153	0.00475	CcSEcCtD
Perhexiline—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00472	CcSEcCtD
Perhexiline—Hepatocellular injury—Epirubicin—uterine cancer	0.0015	0.00466	CcSEcCtD
Perhexiline—Urticaria—Progesterone—uterine cancer	0.00148	0.00461	CcSEcCtD
Perhexiline—Abdominal pain—Progesterone—uterine cancer	0.00148	0.00459	CcSEcCtD
Perhexiline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00457	CcSEcCtD
Perhexiline—Neuropathy peripheral—Etoposide—uterine cancer	0.00147	0.00456	CcSEcCtD
Perhexiline—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00453	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—uterine cancer	0.00142	0.00442	CcSEcCtD
Perhexiline—CYP2D6—female gonad—uterine cancer	0.00139	0.00915	CbGeAlD
Perhexiline—Hepatocellular injury—Doxorubicin—uterine cancer	0.00139	0.00432	CcSEcCtD
Perhexiline—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.0043	CcSEcCtD
Perhexiline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00418	CcSEcCtD
Perhexiline—Asthenia—Progesterone—uterine cancer	0.00134	0.00416	CcSEcCtD
Perhexiline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00416	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—uterine cancer	0.00126	0.00391	CcSEcCtD
Perhexiline—Flushing—Etoposide—uterine cancer	0.00125	0.00388	CcSEcCtD
Perhexiline—Dizziness—Progesterone—uterine cancer	0.00124	0.00384	CcSEcCtD
Perhexiline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00377	CcSEcCtD
Perhexiline—Vomiting—Progesterone—uterine cancer	0.00119	0.00369	CcSEcCtD
Perhexiline—Rash—Progesterone—uterine cancer	0.00118	0.00366	CcSEcCtD
Perhexiline—Dermatitis—Progesterone—uterine cancer	0.00118	0.00366	CcSEcCtD
Perhexiline—Headache—Progesterone—uterine cancer	0.00117	0.00364	CcSEcCtD
Perhexiline—Decreased appetite—Dactinomycin—uterine cancer	0.00115	0.00357	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—uterine cancer	0.00114	0.00354	CcSEcCtD
Perhexiline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00348	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—uterine cancer	0.00112	0.00347	CcSEcCtD
Perhexiline—Nausea—Progesterone—uterine cancer	0.00111	0.00345	CcSEcCtD
Perhexiline—Diplopia—Epirubicin—uterine cancer	0.00109	0.00339	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00108	0.00335	CcSEcCtD
Perhexiline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00334	CcSEcCtD
Perhexiline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00332	CcSEcCtD
Perhexiline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00331	CcSEcCtD
Perhexiline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00329	CcSEcCtD
Perhexiline—Abdominal pain—Dactinomycin—uterine cancer	0.00104	0.00324	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—uterine cancer	0.00103	0.00321	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—STK11—uterine cancer	0.00103	0.0321	CbGpPWpGaD
Perhexiline—Loss of consciousness—Etoposide—uterine cancer	0.00103	0.0032	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—uterine cancer	0.00102	0.00318	CcSEcCtD
Perhexiline—Convulsion—Etoposide—uterine cancer	0.00101	0.00315	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—uterine cancer	0.00101	0.00313	CcSEcCtD
Perhexiline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00312	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—STAR—uterine cancer	0.000996	0.031	CbGpPWpGaD
Perhexiline—Muscular weakness—Epirubicin—uterine cancer	0.000961	0.00299	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—uterine cancer	0.000948	0.00295	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—uterine cancer	0.000947	0.00294	CcSEcCtD
Perhexiline—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000943	0.0293	CbGpPWpGaD
Perhexiline—CPT1A—RORA activates circadian gene expression—EP300—uterine cancer	0.000926	0.0288	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Etoposide—uterine cancer	0.000924	0.00287	CcSEcCtD
Perhexiline—Anorexia—Etoposide—uterine cancer	0.000911	0.00283	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—uterine cancer	0.000889	0.00276	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000865	0.0269	CbGpPWpGaD
Perhexiline—Paraesthesia—Etoposide—uterine cancer	0.000858	0.00267	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—uterine cancer	0.000852	0.00265	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—uterine cancer	0.00084	0.00261	CcSEcCtD
Perhexiline—Rash—Dactinomycin—uterine cancer	0.000833	0.00259	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—uterine cancer	0.000831	0.00258	CcSEcCtD
Perhexiline—Fatigue—Etoposide—uterine cancer	0.000824	0.00256	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000823	0.00256	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—HNF1B—uterine cancer	0.000812	0.0252	CbGpPWpGaD
Perhexiline—Sweating—Epirubicin—uterine cancer	0.000805	0.0025	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—uterine cancer	0.000789	0.00245	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—uterine cancer	0.000784	0.00244	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—uterine cancer	0.000781	0.00243	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000762	0.00237	CcSEcCtD
Perhexiline—Urticaria—Etoposide—uterine cancer	0.000759	0.00236	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—uterine cancer	0.000755	0.00235	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—uterine cancer	0.000754	0.00234	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—uterine cancer	0.000745	0.00231	CcSEcCtD
Perhexiline—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000726	0.0226	CbGpPWpGaD
Perhexiline—Flushing—Epirubicin—uterine cancer	0.0007	0.00217	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—uterine cancer	0.000698	0.00217	CcSEcCtD
Perhexiline—Asthenia—Etoposide—uterine cancer	0.000686	0.00213	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—uterine cancer	0.000647	0.00201	CcSEcCtD
Perhexiline—Tension—Epirubicin—uterine cancer	0.000644	0.002	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000641	0.0199	CbGpPWpGaD
Perhexiline—Nervousness—Epirubicin—uterine cancer	0.000637	0.00198	CcSEcCtD
Perhexiline—Dizziness—Etoposide—uterine cancer	0.000632	0.00196	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000625	0.0194	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000625	0.0194	CbGpPWpGaD
Perhexiline—Vomiting—Etoposide—uterine cancer	0.000608	0.00189	CcSEcCtD
Perhexiline—Rash—Etoposide—uterine cancer	0.000603	0.00187	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—uterine cancer	0.000602	0.00187	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000599	0.0186	CbGpPWpGaD
Perhexiline—Headache—Etoposide—uterine cancer	0.000599	0.00186	CcSEcCtD
Perhexiline—Tension—Doxorubicin—uterine cancer	0.000596	0.00185	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000591	0.0184	CbGpPWpGaD
Perhexiline—Nervousness—Doxorubicin—uterine cancer	0.00059	0.00183	CcSEcCtD
Perhexiline—Syncope—Epirubicin—uterine cancer	0.000589	0.00183	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—uterine cancer	0.000577	0.00179	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—uterine cancer	0.000569	0.00177	CcSEcCtD
Perhexiline—Nausea—Etoposide—uterine cancer	0.000568	0.00176	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—uterine cancer	0.000545	0.00169	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—uterine cancer	0.000534	0.00166	CcSEcCtD
Perhexiline—Shock—Epirubicin—uterine cancer	0.000527	0.00164	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—uterine cancer	0.000526	0.00163	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—EZH2—uterine cancer	0.000521	0.0162	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Epirubicin—uterine cancer	0.000518	0.00161	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—uterine cancer	0.000511	0.00159	CcSEcCtD
Perhexiline—CPT1A—Circadian Clock—EP300—uterine cancer	0.000493	0.0153	CbGpPWpGaD
Perhexiline—Shock—Doxorubicin—uterine cancer	0.000488	0.00151	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—uterine cancer	0.000485	0.00151	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—uterine cancer	0.000481	0.00149	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000479	0.00149	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—uterine cancer	0.000472	0.00147	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—uterine cancer	0.000466	0.00145	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—uterine cancer	0.000462	0.00143	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000459	0.0143	CbGpPWpGaD
Perhexiline—Insomnia—Doxorubicin—uterine cancer	0.000448	0.00139	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—uterine cancer	0.000445	0.00138	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000438	0.00136	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000433	0.0135	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000433	0.0135	CbGpPWpGaD
Perhexiline—Decreased appetite—Doxorubicin—uterine cancer	0.000431	0.00134	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—uterine cancer	0.000427	0.00133	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—uterine cancer	0.000426	0.00132	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—uterine cancer	0.000423	0.00132	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—EP300—uterine cancer	0.000408	0.0127	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000405	0.00126	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.0004	0.0124	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—uterine cancer	0.000394	0.00122	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—uterine cancer	0.000392	0.00122	CcSEcCtD
Perhexiline—CPT2—Metabolism—SRD5A2—uterine cancer	0.000385	0.012	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NDUFB11—uterine cancer	0.000385	0.012	CbGpPWpGaD
Perhexiline—Asthenia—Epirubicin—uterine cancer	0.000384	0.00119	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000374	0.0116	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000371	0.0115	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000366	0.0114	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000356	0.0111	CbGpPWpGaD
Perhexiline—Asthenia—Doxorubicin—uterine cancer	0.000356	0.0011	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—uterine cancer	0.000354	0.0011	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000353	0.011	CbGpPWpGaD
Perhexiline—Vomiting—Epirubicin—uterine cancer	0.000341	0.00106	CcSEcCtD
Perhexiline—Rash—Epirubicin—uterine cancer	0.000338	0.00105	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—uterine cancer	0.000337	0.00105	CcSEcCtD
Perhexiline—Headache—Epirubicin—uterine cancer	0.000336	0.00104	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—uterine cancer	0.000328	0.00102	CcSEcCtD
Perhexiline—Nausea—Epirubicin—uterine cancer	0.000318	0.000989	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000318	0.00989	CbGpPWpGaD
Perhexiline—Vomiting—Doxorubicin—uterine cancer	0.000315	0.000979	CcSEcCtD
Perhexiline—Rash—Doxorubicin—uterine cancer	0.000313	0.000971	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—uterine cancer	0.000312	0.00097	CcSEcCtD
Perhexiline—Headache—Doxorubicin—uterine cancer	0.000311	0.000965	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—uterine cancer	0.000304	0.00946	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000301	0.00935	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—uterine cancer	0.000294	0.000915	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—TP53—uterine cancer	0.000294	0.00915	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000283	0.00881	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—EP300—uterine cancer	0.000283	0.0088	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—STAR—uterine cancer	0.000278	0.00866	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKR1B1—uterine cancer	0.000278	0.00866	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000277	0.00862	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000275	0.00857	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000275	0.00856	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000273	0.00849	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000269	0.00838	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SRD5A2—uterine cancer	0.000267	0.0083	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NDUFB11—uterine cancer	0.000267	0.0083	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000263	0.00819	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000259	0.00806	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000258	0.00802	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000254	0.00791	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.00025	0.00776	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—uterine cancer	0.000248	0.00773	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000245	0.00761	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.00023	0.00716	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000221	0.00688	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—POLD1—uterine cancer	0.000218	0.00679	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000214	0.00666	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000209	0.0065	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKR1C1—uterine cancer	0.000204	0.00635	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000203	0.00631	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000197	0.00612	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000193	0.00601	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKR1B1—uterine cancer	0.000193	0.006	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—STAR—uterine cancer	0.000193	0.006	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000191	0.00594	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000191	0.00593	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00019	0.0059	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000187	0.00582	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—uterine cancer	0.000183	0.0057	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000183	0.00569	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—RRM2—uterine cancer	0.000182	0.00566	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—DCN—uterine cancer	0.000177	0.0055	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—EP300—uterine cancer	0.000175	0.00544	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	0.00017	0.00528	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000169	0.00524	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP11A1—uterine cancer	0.000167	0.00518	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000166	0.00517	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	0.00016	0.00497	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000158	0.0049	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKR1C3—uterine cancer	0.000157	0.00489	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000154	0.00478	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000153	0.00477	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—POLD1—uterine cancer	0.000151	0.00471	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000149	0.00463	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKR1C1—uterine cancer	0.000142	0.0044	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000137	0.00425	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000134	0.00418	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000129	0.004	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—RRM2—uterine cancer	0.000126	0.00393	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—uterine cancer	0.000125	0.00389	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000124	0.00386	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—DCN—uterine cancer	0.000123	0.00381	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP19A1—uterine cancer	0.000123	0.00381	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—STK11—uterine cancer	0.000123	0.00381	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000122	0.00381	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.00012	0.00372	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000118	0.00367	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	0.000118	0.00365	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000116	0.0036	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP11A1—uterine cancer	0.000115	0.00359	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000115	0.00358	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000111	0.00345	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.00011	0.00341	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.00011	0.00341	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKR1C3—uterine cancer	0.000109	0.00339	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000103	0.00322	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000101	0.00313	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MTHFR—uterine cancer	9.21e-05	0.00286	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	8.78e-05	0.00273	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—STK11—uterine cancer	8.49e-05	0.00264	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP19A1—uterine cancer	8.49e-05	0.00264	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	8.17e-05	0.00254	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.11e-05	0.00252	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	8.06e-05	0.00251	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.97e-05	0.00248	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	7.71e-05	0.0024	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.6e-05	0.00236	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	7.26e-05	0.00226	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	7.16e-05	0.00223	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	6.76e-05	0.0021	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTHFR—uterine cancer	6.38e-05	0.00198	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SRD5A2—uterine cancer	6.32e-05	0.00196	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NDUFB11—uterine cancer	6.32e-05	0.00196	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.62e-05	0.00175	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	5.34e-05	0.00166	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.27e-05	0.00164	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—uterine cancer	5.12e-05	0.00159	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—EP300—uterine cancer	4.89e-05	0.00152	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKR1B1—uterine cancer	4.57e-05	0.00142	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—STAR—uterine cancer	4.57e-05	0.00142	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NDUFB11—uterine cancer	4.39e-05	0.00136	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SRD5A2—uterine cancer	4.39e-05	0.00136	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—uterine cancer	3.61e-05	0.00112	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—POLD1—uterine cancer	3.58e-05	0.00111	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—uterine cancer	3.55e-05	0.0011	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—uterine cancer	3.39e-05	0.00105	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKR1C1—uterine cancer	3.35e-05	0.00104	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKR1B1—uterine cancer	3.17e-05	0.000987	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—STAR—uterine cancer	3.17e-05	0.000987	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RRM2—uterine cancer	2.99e-05	0.000929	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—uterine cancer	2.95e-05	0.000918	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DCN—uterine cancer	2.9e-05	0.000902	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.87e-05	0.000892	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.87e-05	0.000892	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP11A1—uterine cancer	2.73e-05	0.00085	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.58e-05	0.000802	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—uterine cancer	2.5e-05	0.000779	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—POLD1—uterine cancer	2.49e-05	0.000774	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.33e-05	0.000724	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RRM2—uterine cancer	2.08e-05	0.000646	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.07e-05	0.000645	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—STAR—uterine cancer	2.07e-05	0.000645	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—uterine cancer	2.05e-05	0.000636	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DCN—uterine cancer	2.02e-05	0.000627	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—STK11—uterine cancer	2.01e-05	0.000625	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP19A1—uterine cancer	2.01e-05	0.000625	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.9e-05	0.00059	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.79e-05	0.000558	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—POLD1—uterine cancer	1.63e-05	0.000506	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.52e-05	0.000474	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—uterine cancer	1.51e-05	0.00047	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.4e-05	0.000434	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—STK11—uterine cancer	1.4e-05	0.000434	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RRM2—uterine cancer	1.36e-05	0.000422	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DCN—uterine cancer	1.32e-05	0.00041	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.24e-05	0.000386	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000365	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—uterine cancer	1.05e-05	0.000326	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—STK11—uterine cancer	9.13e-06	0.000284	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.13e-06	0.000284	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—uterine cancer	8.4e-06	0.000261	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—uterine cancer	8.01e-06	0.000249	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—uterine cancer	6.86e-06	0.000213	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—uterine cancer	5.93e-06	0.000184	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—uterine cancer	5.84e-06	0.000182	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—uterine cancer	5.57e-06	0.000173	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—uterine cancer	4.84e-06	0.000151	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.12e-06	0.000128	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—uterine cancer	3.82e-06	0.000119	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—uterine cancer	3.64e-06	0.000113	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—uterine cancer	3.37e-06	0.000105	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.69e-06	8.38e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—uterine cancer	2.2e-06	6.84e-05	CbGpPWpGaD
